“护手霜爱马仕”重新申请上市

Core Insights - L'Occitane Groupe, known for its iconic hand cream, is planning to return to the capital market with an IPO in the US after being privatized in Hong Kong in 2024 [2][5][14] - The company aims to leverage the current recovery in capital markets to achieve a higher valuation through its upcoming IPO [5][15] Company Overview - Founded in 1976 by Olivier Baussan, L'Occitane is a high-end personal care brand based in Provence, France, focusing on natural plant-based products [6][9] - The brand's flagship product, the shea butter hand cream, is often referred to as the "Hermès of hand creams," achieving sales of one unit every four seconds [6][9] Market Position and Strategy - L'Occitane has expanded its brand portfolio to include Melvita, ELEMIS, and Sol de Janeiro, with products available in 90 countries [8][9] - The company has historically relied on a combination of star products, international market expansion, and strategic acquisitions to grow its business [9][13] Financial Performance - The company reported a revenue of €2.8 billion (approximately ¥228.02 billion) for the fiscal year 2025, reflecting an 11.7% year-on-year growth, although growth rates have slowed compared to previous years [16][18] - The brand's largest market is now the US, which has seen its sales share increase from 14.1% to 27.2%, while the Chinese market's share has declined from 18.4% to 12.9% [14][18] Challenges and Developments - L'Occitane faces significant challenges, including declining sales in China, leadership changes, and difficulties with brand acquisitions [14][15][20] - The company has initiated a restructuring of its leadership and has made strategic decisions, such as selling the Grown Alchemist brand for €28.35 million (approximately ¥2.17 billion) [14][15] Future Outlook - The upcoming IPO is seen as a potential opportunity for L'Occitane to raise funds and enhance operational efficiency, but the company must address its channel shortcomings and competitive positioning in the market [23]